Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 12:47PM ET
Dollar change
Percentage change
IndexRUT P/E11.01 EPS (ttm)0.67 Insider Own4.52% Shs Outstand72.73M Perf Week1.03%
Market Cap538.24M Forward P/E- EPS next Y-0.25 Insider Trans3.05% Shs Float70.16M Perf Month41.96%
Income49.14M PEG0.55 EPS next Q0.10 Inst Own91.71% Short Float / Ratio4.68% / 6.21 Perf Quarter13.39%
Sales452.67M P/S1.19 EPS this Y317.33% Inst Trans-4.39% Short Interest3.28M Perf Half Y32.46%
Book/sh5.51 P/B1.33 EPS next Y-146.47% ROA11.04% Target Price6.00 Perf Year51.66%
Cash/sh3.06 P/C2.39 EPS next 5Y20.00% ROE13.16% 52W Range4.38 - 7.82 Perf YTD51.97%
Dividend- P/FCF7.08 EPS past 5Y- ROI11.79% 52W High-6.33% Beta0.21
Dividend %- Quick Ratio7.26 Sales past 5Y21.36% Gross Margin41.12% 52W Low67.43% ATR0.23
Employees840 Current Ratio8.71 Sales Q/Q-23.42% Oper. Margin10.93% RSI (14)77.10 Volatility2.35% 4.06%
OptionableYes Debt/Eq0.04 EPS Q/Q107.32% Profit Margin10.86% Rel Volume0.45 Prev Close7.27
ShortableYes LT Debt/Eq0.03 EarningsNov 07 AMC Payout- Avg Volume528.88K Price7.32
Recom2.67 SMA2011.59% SMA5022.69% SMA20024.30% Volume124,743 Change0.76%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Evercore ISI In-line $5
Sep-22-21Downgrade Raymond James Outperform → Mkt Perform
Aug-21-20Initiated Evercore ISI Outperform $22
Aug-10-20Initiated JP Morgan Neutral $18
Aug-10-20Initiated Citigroup Buy $18
Aug-07-20Upgrade Raymond James Mkt Perform → Outperform $16
Jun-25-20Initiated Lake Street Buy $19
Apr-21-20Resumed Stephens Equal-Weight $14
Oct-23-18Resumed Raymond James Mkt Perform
Jul-16-18Downgrade Stephens Overweight → Equal-Weight
Nov-27-23 09:55AM
Nov-13-23 04:15PM
Nov-09-23 11:12AM
Nov-08-23 12:14PM
06:50PM Loading…
Nov-07-23 06:50PM
Oct-23-23 04:05PM
Aug-09-23 06:02AM
Aug-05-23 08:52AM
Aug-04-23 11:45AM
Aug-03-23 05:55PM
04:05PM Loading…
Jul-20-23 04:05PM
Jun-29-23 07:07AM
Jun-21-23 08:00PM
Jun-13-23 04:05PM
Jun-08-23 11:03AM
Jun-01-23 06:29AM
May-16-23 06:08AM
May-12-23 07:12AM
May-11-23 11:03AM
May-10-23 05:35PM
May-03-23 07:05AM
08:00PM Loading…
Apr-26-23 08:00PM
Apr-21-23 09:40AM
Apr-05-23 08:38AM
Mar-29-23 07:30AM
Mar-21-23 07:22AM
Mar-20-23 07:20AM
Mar-08-23 11:53AM
Feb-23-23 12:20PM
Feb-16-23 04:38PM
Feb-15-23 03:48PM
Feb-14-23 06:05PM
Feb-07-23 07:05AM
Dec-21-22 07:52AM
Dec-01-22 07:05AM
Nov-14-22 07:05AM
Nov-08-22 06:05PM
Nov-03-22 09:15AM
Nov-02-22 07:05AM
Nov-01-22 07:05AM
Oct-07-22 09:14AM
Oct-01-22 10:30AM
Sep-28-22 10:28AM
Sep-20-22 04:05PM
Sep-14-22 07:05AM
Aug-31-22 06:29AM
Aug-14-22 08:28AM
Aug-09-22 07:25PM
Aug-02-22 07:05AM
Jul-28-22 07:05AM
Jul-14-22 08:42AM
Jun-14-22 08:31AM
Jun-08-22 04:05PM
May-25-22 07:05AM
May-23-22 04:05PM
May-17-22 07:05AM
May-10-22 06:55PM
May-04-22 06:45PM
May-03-22 04:05PM
Apr-24-22 10:21AM
Apr-07-22 07:05AM
Mar-31-22 07:05AM
Mar-22-22 04:05PM
Feb-23-22 04:05PM
Feb-16-22 04:05PM
Jan-31-22 07:54AM
Jan-25-22 07:05AM
Jan-24-22 10:04AM
Jan-19-22 05:38PM
Jan-13-22 04:05PM
Jan-06-22 11:09AM
Jan-05-22 04:24PM
Dec-14-21 07:05AM
Nov-30-21 07:05AM
Nov-19-21 07:05AM
Nov-11-21 09:34AM
Nov-09-21 07:05AM
Nov-08-21 07:05AM
Nov-04-21 12:31AM
Nov-03-21 07:15PM
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anthony Michele MarieSVP Finance & CAOAug 15Option Exercise5.711,75810,03887,946Aug 17 04:27 PM
Anthony Michele MarieSVP Finance & CAOAug 15Sale6.501,75811,42786,188Aug 17 04:27 PM
McGrath Kenneth JChief Financial OfficerMay 30Buy4.93100,000492,810285,512May 31 04:14 PM